|
G3BP2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.63753513158372E-14 |
| Normal-vs-Stage2 |
1.07540000005013E-06 |
| Normal-vs-Stage3 |
5.88418203051333E-15 |
| Normal-vs-Stage4 |
1.62436730732907E-12 |
| Stage1-vs-Stage2 |
9.955400E-01 |
| Stage1-vs-Stage3 |
2.678300E-02 |
| Stage1-vs-Stage4 |
3.642600E-04 |
| Stage2-vs-Stage3 |
1.557790E-01 |
| Stage2-vs-Stage4 |
2.150400E-02 |
| Stage3-vs-Stage4 |
3.078800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62492241884138E-12 |
| Normal-vs-AfricanAmerican |
1.6251444634463E-12 |
| Normal-vs-Asian |
5.476400E-03 |
| Caucasian-vs-AfricanAmerican |
1.690330E-02 |
| Caucasian-vs-Asian |
6.832000E-01 |
| AfricanAmerican-vs-Asian |
1.556780E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
2.17059703544464E-12 |
| Male-vs-Female |
6.422000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.54779555628215E-11 |
| Normal-vs-Age(41-60Yrs) |
1.64468438867971E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
1.58780000036884E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.152640E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.953610E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.460200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.777000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.314200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.690600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.006800E-04 |
| Normal-vs-Grade 2 |
3.62454510849375E-12 |
| Normal-vs-Grade 3 |
<1E-12 |
| Normal-vs-Grade 4 |
1.62458935193399E-12 |
| Grade 1-vs-Grade 2 |
9.021000E-01 |
| Grade 1-vs-Grade 3 |
3.577400E-01 |
| Grade 1-vs-Grade 4 |
3.496500E-02 |
| Grade 2-vs-Grade 3 |
3.296500E-02 |
| Grade 2-vs-Grade 4 |
8.09620000000733E-05 |
| Grade 3-vs-Grade 4 |
2.960300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.43650005621521E-10 |
| Normal-vs-ccB subtype |
1.62736490949555E-12 |
| ccA subtype-vs-ccB subtype |
9.542300E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.63347113613099E-12 |
| Normal-vs-N1 |
1.703480E-03 |
| N0-vs-N1 |
5.611800E-01 |
|
|
